Clinical trials
Terminated Urinary Bladder, Overactive trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 6 |
| 2007 | 5 |
| 2008 | 9 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 5 |
| 2015 | 4 |
| 2016 | 8 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 65 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ipsen | 3 |
| Mayo Clinic | 3 |
| Allergan | 2 |
| Corewell Health East | 2 |
| Laborie Medical Technologies Inc. | 2 |
| MedtronicNeuro | 2 |
| Vanderbilt University Medical Center | 2 |
| Advanced Research Network | 1 |
| Amphora Medical, Inc. | 1 |
| Astellas Pharma Europe Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder, Overactive | 65 |
| Urinary Incontinence | 12 |
| Urinary Incontinence, Urge | 12 |
| Lower Urinary Tract Symptoms | 3 |
| Multiple Sclerosis | 2 |
| Spinal Cord Injuries | 2 |
| Urinary Tract Infections | 2 |
| Anxiety Disorders | 1 |
| Constipation | 1 |
| Fecal Incontinence | 1 |
Trials
Showing 76 to 65 of 65. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.